Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
ROSSI TYSON
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2022-01-10
|
3. Issuer Name and Ticker or Trading Symbol
MedMen Enterprises, Inc. [MMNFF]
|
|
(Last)
|
(First)
|
(Middle)
|
|
10115 JEFFERSON BOULEVARD
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
Ch. Strategy Officer /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
|
CULVER CITY
|
CA
|
90232
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
ROSSI TYSON
10115 JEFFERSON BOULEVARD
CULVER CITY, CA90232
|
|
|
Ch. Strategy Officer
|
|
Signatures
|
/s/ Tyson Rossi
|
2022-01-26
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
Represents restricted stock units ("RSUs"), granted 9/9/2020 pursuant to Issuer's 2018 Stock and Incentive Plan (the "Incentive Plan"), which vest annually over four years with 37.5% vesting on 6/30/2021 and 6/30/2023, and 12.5% vesting on 6/30/2022 and 6/30/24. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
|
|
(2)
|
Represents RSUs granted 8/29/2021 pursuant to the Incentive Plan, which vest annually over four years with 37.5% vesting on 6/30/2022 and 6/30/2024, and 12.5% vesting on 6/30/2023 and 6/30/25. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
|
|
(3)
|
Employee stock options (right to buy) ("Options") granted pursuant to the Incentive Plan.
|
|
(4)
|
Options have an exercise price of CAN$2.64, which is equivalent to US$1.9858 at an exchange rate of 0.7522 as of the grant date.
|
|
(5)
|
Options have an exercise price of CAN$0.22, which is equivalent to US$0.1670 at an exchange rate of 0.7591 as of the grant date.
|
|
(6)
|
Options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 0.7925 as of the grant date.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
